Sialivac: An intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry

Vaccine

Volumn 27, Issue 31, 2009, Pages 4161-4168

  Worrall, E E ^a   Sudarisman, ^b   Priadi, A ^c  

^a Ty Mawr   (United Kingdom)

^b Local Disease Control Center (LDCC) Bogor   (Indonesia)

^c PT Peternakan Ayam Manggis   (Indonesia)

Author keywords

Chitosan; Homologous split virus; HP H5N1; Intranasal vaccine; Sialidase

Indexed keywords

AVIAN INFLUENZA VACCINE; CHITOSAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; SIALIDASE; SIALIVAC; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; AVIAN INFLUENZA; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; INCIDENCE; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H5N2; MUCOSAL IMMUNITY; NONHUMAN; POULTRY; PRIORITY JOURNAL; VIRUS STRAIN; VIRUS VIRULENCE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; BACTERIAL PROTEINS; CHITOSAN; CLOSTRIDIUM PERFRINGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION TESTS; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H5N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; NEURAMINIDASE; POULTRY; POULTRY DISEASES; SURVIVAL ANALYSIS; VACCINES, SUBUNIT; VIRUS SHEDDING;

EID: 67349124780     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.04.058     Document Type: Article

References (26)

1. Greger M. Bird flu, a virus of our own hatching (2006), Lantern Books. 1-59056-098-1 p. 160-213
2. Cacalano G., Kays M., Salman L., and Prince A. Production of the Pseudomonas aeruginosa neuraminidase is increased under hyperosmolar conditions and is regulated by genes involved in alginate expression. J Clin Invest 89 (1992) 1866-1874
3. Tumpey T.M., Renshaw M., Clements J.D., and Katz J.M. Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross protection against lethal influenza A H5N1 virus infection. J Virol (2001) 5141-5150
4. Stephenson I., Zambon M.C., Rudin A., Colgate A., Podda A., Bugarini R., et al. Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers. J Virol 80 10 (2006) 4962-4970
5. Takada A., Matsushita S., Ninomiya A., Kawaoka Y., and Kida H. Intranasal immunisation with formalin inactivated virus vaccine induces broad spectrum heterosubtypic immunity against Influenza A virus infection in mice. Vaccine 21 (2003) 3212-3218
6. Tamura S., Asanuma H., and Ito Y. Formulation of inactivated influenza vaccines for providing effective cross protection by intranasal vaccination in mice. Vaccine 12 (1994) 310-316
7. Crennell S.J., Garman E.F., Laver W.G., Vimr E.R., and Taylor G.L. Crystal structure of a bacterial sialidase (from Salmonella typhimuriam LT2) shows the same fold as an influenza virus neuraminidase. Proc Natl Acad Sci USA Biochem 90 (1993) 9852-9856
8. Cassidy J.T., Jourdian G.W., and Roseman S. Purification and properties of sialidase from Clostridium perfringens. J Biol Chem 240 9 (1965) 3501-3506
9. McCrea J.F. Clostridium perfringens neuraminidase was found to occupy myxovirus receptors on red blood cells following treatment with dilute culture filtrates preventing agglutination by myxoviruses. Aust J Exp Med Sci 25 (1947) 127
10. Diao J., Winter E., Chen W., Xu F., and Cattral M.S. Antigen transmission by replicating antigen-bearing dendritic cells. J Immunol 179 (2007) 2713-2721
11. Nicholls J.M., Chan M.C.W., Chan W.Y., Wong H.K., Cheung C.Y., Kwong D.L.W., et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 13 (2007) 147-149
12. Kwong M.P., Chui W.H., Poon L.L.M., Tsao S.W., Guan Y., and Pereis J.S.M. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 13 (2007) 147-149
13. Garman E., and Laver G. Curr Drug Targets 5 2 (2004) 119-136
14. Schnell J.R., and Chou J.J. Structure and mechanism of the M2 proton channel of influenza A virus. Nature 451 (2008) 591-595 doi: 10. 1038/nature 06531
15. Russell R.J., Haire L.F., Stevens D.J., Collins P.J., Lin Y.P., Blackburn G.M., et al. The structure of H5N1 avian influenza neuramindase suggests new opportunities for drug design. Nature 443 7107 (2006) 45-49
16. Von Itzstein M., Wu W.Y., Kok G.B., Pegg M.S., Dyason J.C., Van Than T., et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363 6428 (1993) 418-423
17. Taylor N.R., Cleasby A., Singh O., Skarzynski T., Wonacott A.J., Smith P.W., et al. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modelling study of complexes of 4-amino-4H-pyran-6 carboxamides and sialidase from influenza types A and B. J Med Chem 41 6 (1998) 798-807
18. Soong G., Muir A., Gomez M.I., Waks J., Reddy B., Planet P., et al. Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J. Clin Invest 116 8 (2006) 2297-2305
19. Pinto L.H., and Lamb R.A. The M2 proton chanel of influenza A and B viruses. J Biol Chem 281 14 (2006) 8997-9000
20. Cripps A.W., Peek K., Dunkley M., Vento K., Marjarsan J.K., McIntyre M.E., et al. Safety and Immunogenicity of an oral inactivated whole-cell Pseudomonas aeroginosa vaccine administered to healthy human subjects. Infect Immun 72 2 (2006) 968-974
21. Lindsay M.A. MicroRNAs and the immune response. Trends Immunol 29 7 (2008) 343-351
22. Luo M. Structural biology: antiviral drugs fit for a purpose. Nature 443 (2006) 37-38 doi:10.1038/nature 05003
23. Kim C.U., Lew W., Williams M.A., Liu H., Zhang L., Swaminathan S., et al. Inflenza neuramindase inhibitors posessing a novel hydrophobic interaction in the enzyme active site: design, sythesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J Am Chem Soc 119 4 (1997) 681-690
24. Van Kammen A. Report on avian virology techniques (1982), Department of Tropical Veterinary Science, James Cook University, North Queensland, Australia
25. WHO. WHO manual on avian influenza diagnosis and surveillance. Department of Communicable Disease Surveillance and Response. WHO Global Influenza Programme; 2002. p. 37-9.
26. Trevor Willis A. Clostridia of wound infection (1969), Butterworths, London p. 75